XRX Stock Analysis: Xerox | NASDAQ
Business Equipment & Supplies | NASDAQ, USA | Market Cap: 436m USD | 12M Return: -3.1% | US98421M1062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.07M
Qual. Beats: 1
Rev. Trend: 34.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Xerox Holdings Corporation (NASDAQ: XRX) is a workplace technology company that designs, develops, and sells document systems, solutions, and related services to enterprises worldwide. Founded in 1903 and headquartered in Norwalk, Connecticut, Xerox operates through two main segments: Print and Other, and Xerox Financial Services (XFS), which provides equipment financing and lease arrangements. Its product portfolio spans A4 desktop printers (Entry), A3 multifunction devices (Mid-range), ConnectKey software, and production solutions such as xerographic and inkjet presses alongside its FreeFlow workflow software. Service offerings include Managed Print Services, IT solutions, Capture and Content Services, and Customer Engagement Services, supplemented by tools such as DocuShare, CareAR, and XMPie. The company distributes through a direct sales force along with distributors, dealers, value-added resellers, systems integrators, and e-commerce channels, and also invests in early- and mid-stage growth companies.
As one of the original pioneers of office reprographics, Xerox has shifted its business model away from reliance on equipment sales toward a hybrid of hardware, software, and recurring managed-services revenue, a transition common across the broader Technology Hardware, Storage & Peripherals sub-industry as enterprise customers increasingly digitize document workflows. This segment is classified within the Information Technology sector and is considered Small Cap.
- Print revenue declines accelerate amid digital shift
- Xerox Financial Services portfolio performance drives recurring income
- Debt refinancing and restructuring actions pressure capital allocation
| Net Income: -925.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.45 > 1.0 |
| NWC/Revenue: 7.36% < 20% (prev 18.09%; Δ -10.73% < -1%) |
| CFO/TA 0.04 > 3% & CFO 386.0m > Net Income -925.0m |
| Net Debt (4.05b) to EBITDA (356.0m): 11.39 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.0m) vs 12m ago 13.68% < -2% |
| Gross Margin: 27.91% > 18% (prev 29.61%; Δ -1.70% > 0.5%) |
| Asset Turnover: 83.42% > 50% (prev 69.57%; Δ 13.84% > 0%) |
| Interest Coverage Ratio: -0.17 > 6 (EBIT TTM -59.0m / Interest Expense TTM 344.0m) |
| A: 0.06 (Total Current Assets 3.70b - Total Current Liabilities 3.13b) / Total Assets 9.72b |
| B: 0.24 (Retained Earnings 2.33b / Total Assets 9.72b) |
| C: -0.01 (EBIT TTM -59.0m / Avg Total Assets 9.30b) |
| D: 0.06 (Book Value of Equity 544.0m / Total Liabilities 9.17b) |
| Altman-Z'' = 1.18 = BB |
| DSRI: 0.63 (Receivables 1.19b/1.49b, Revenue 7.76b/6.17b) |
| GMI: 1.06 (GM 29.61% / 27.91%) |
| AQI: 0.96 (AQ_t 0.55 / AQ_t-1 0.57) |
| SGI: 1.26 (Revenue 7.76b / 6.17b) |
| TATA: -0.13 (NI -925.0m - CFO 386.0m) / TA 9.72b) |
| Beneish M = -3.13 (Cap -4..+1) = AA |
As of September 12, 2026, the stock is trading at USD 3.43 with a total of 3,570,662 shares traded. Over the past week, the price has changed by +3.94%, over one month by +6.52%, over three months by -0.37% and over the past year by -3.09%.
Current recommended Stop Loss: 3.20 (which is 6.7% or 1.2 ATR below the current price).
Xerox has received a consensus analysts rating of 2.80. Therefore, it is recommended to hold XRX.
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 3.8 | 11.4% |
P/E Forward = 2.2242
P/S = 0.0562
P/B = 1.2928
P/EG = 0.1519
Revenue TTM = 7.76b USD
EBIT TTM = -59.0m USD
EBITDA TTM = 356.0m USD
Long Term Debt = 4.15b USD (from longTermDebt, last quarter)
Short Term Debt = 70.0m USD (from shortTermDebt, last quarter)
Debt = 4.55b USD (from shortLongTermDebtTotal, last quarter) + Leases 327.0m
Net Debt = 4.05b USD (calculated: Debt 4.55b - CCE 495.0m)
Enterprise Value = 4.49b USD (436.0m + Debt 4.55b - CCE 495.0m)
Interest Coverage Ratio = -0.17 (Ebit TTM -59.0m / Interest Expense TTM 344.0m)
EV/FCF = 15.65x (Enterprise Value 4.49b / FCF TTM 287.0m)
FCF Yield = 6.39% (FCF TTM 287.0m / Enterprise Value 4.49b)
FCF Margin = 3.70% (FCF TTM 287.0m / Revenue TTM 7.76b)
Net Margin = -11.92% (Net Income TTM -925.0m / Revenue TTM 7.76b)
Gross Margin = 27.91% ((Revenue TTM 7.76b - Cost of Revenue TTM 5.59b) / Revenue TTM)
Gross Margin QoQ = 35.80% (prev 28.11%)
Tobins Q-Ratio = 0.46 (Enterprise Value 4.49b / Total Assets 9.72b)
Interest Expense / Debt = 7.56% (Interest Expense 344.0m / Debt 4.55b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -46.6m (EBIT -59.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.18 (Total Current Assets 3.70b / Total Current Liabilities 3.13b)
Debt / Equity = 8.36 (Debt 4.55b / totalStockholderEquity, last quarter 544.0m)
Debt / EBITDA = 11.39 (Net Debt 4.05b / EBITDA 356.0m)
Debt / FCF = 14.13 (Net Debt 4.05b / FCF TTM 287.0m)
Total Stockholder Equity = 573.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -9.95% (Net Income -925.0m / Total Assets 9.72b)
RoE = -161.3% (Net Income TTM -925.0m / Total Stockholder Equity 573.5m)
RoCE = -1.25% (EBIT -59.0m / Capital Employed (Equity 573.5m + L.T.Debt 4.15b))
RoIC = -0.74% (negative operating profit) (NOPAT -46.6m / Invested Capital 6.28b)
WACC = 6.93% (E(436.0m)/V(4.99b) * Re(16.94%) + D(4.55b)/V(4.99b) * Rd(7.56%) * (1-Tc(0.21)))
Discount Rate = 16.94% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 72.19 | Cagr: 6.57%
[DCF] Terminal Value 74.74% ; FCFF base≈293.0m ; Y1≈282.0m ; Y5≈274.4m
[DCF] Fair Price = 1.92 (EV 4.31b - Net Debt 4.05b = Equity 252.5m / Shares 131.3m; r=8.35% [WACC [floored]]; 5y FCF grow -4.97% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.00 | # QB: 1
Revenue Correlation: 34.77 | Revenue CAGR: 2.88% | SUE: 0.32 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.12 | Chg30d=-362.63% | Revisions=-40% | Analysts=2
EPS current Year (2026-12-31): EPS=0.14 | Chg30d=+148.78% | Revisions=+40% | GrowthEPS=+122.7% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=0.30 | Chg30d=-67.38% | Revisions=+0% | GrowthEPS=+121.9% | GrowthRev=-1.8%
[Analyst] Revisions Ratio: +0% (up=2, down=2)